Latest News


Archive for the ‘Comprehensive Cancer Information’ Category

John Hopkins Medicine

Posted on: No Comments

More Arrows in the Arsenal
By David Glenn
Illustration by Traci Daberko | Photos by Justin Tsucalas
Dramatic advances in immunotherapy offer new options for patients with advanced melanoma—and could even make chemotherapy a thing of the past.
 
As with many other cancers, metastatic melanoma cells have dozens of wicked capacities.… Read the rest

Immune Therapy’s Promise

Posted on: No Comments

A new class of medicines that help the body’s own immune cells fight tumors could target a wide set of cancers, opening a $35 billion market for Merck (MRK) & Co., Bristol-Myers Squibb Co., AstraZeneca Plc and Roche (ROG) Holding AG.… Read the rest

Melanoma Risk Assessment

Sun exposure, family history guide risk assessment for melanoma screening
April 14, 2014

NEW YORK — Several factors can help better define individuals at high risk for melanoma, according to a presenter at the HemOnc Today Melanoma and Cutaneous Malignancies meeting.… Read the rest

Immunotherapy shows promise against melanoma

Article published in the Global Post, June 2014, ASCO MEETING

 
 
 
 
 
By unleashing the immune system to attack skin cancer, researchers have made important strides against melanoma, according to the results of three clinical trials released Monday.… Read the rest

Exercise reduces cancer risk

New Evidence on How Weight, Diet and Exercise can help reduce cancer risk.
By Suzanne Allard Levingston,Published: February 18,2014 WASHINGTON POST

Cutting your risk of cancer is no longer just about shunning tobacco. Be lean. Eat healthfully. Get active. Common-sense lifestyle strategies for lowering the risk of heart disease and diabetes are now being shown to help prevent many types of cancer.
 … Read the rest

Free Skin Screening

Sign up with JacksFund or at HealthTrack.
Thank you to Shannon Morrow, PA-C from Dermatology Associates of LaGrange for again volunteering her time.
A screening should NOT take the place of your annual checkup.

 … Read the rest

Vemurafenib Comination Effective in Advanced BRAF-Mutant Melanoma

Encouraging Data:
OncLive: Silas Inman
Published Online: Wednesday, May 7, 201
 
 
The combination of the BRAF inhibitor vemurafenib (Zelboraf) with the investigational MEK inhibitor cobimetinib (GDC-0973) demonstrated a 13.7-month median progression-free survival (PFS) and an overall response rate (ORR) of 87% in treatment-naïve patients with BRAFV600 mutation-positive metastatic melanoma, according to phase Ib results presented at the 10th European Association of Dermato Oncology Congress in Vilnius, Lithuania.… Read the rest

Ipilimumab std of care

Ipilimumab may become standard of care for adjuvant melanoma therapy
April 11, 2014
 NEW YORK — Ipilimumab will replace interferon as the standard of care for adjuvant therapy of melanoma, but key questions remain about appropriate patient selection and dosing, according to a presenter at the HemOnc Today Melanoma and Cutaneous Malignancies meeting.
 … Read the rest

Immunotherapy for melanoma

Immunotherapy for melanoma progresses with some interesting response patterns
By: SHARON WORCESTER, Oncology Report Digital Network
HOLLYWOOD, FLA. – Tremendous progress has been made in recent years in the area of immunotherapy for the treatment of melanoma, and new agents and combinations continue to emerge, with some interesting response patterns, according to Dr.… Read the rest

Drug blocks spread of disease

Drug is identified that could block the spread of melanoma
by Zach Veilleux
 
By treating melanoma tumors with a compound called GW3965, researchers found they could reduce the tumor’s recruitment of blood vessels (red areas, bottom) when compared to a conventional anti-tumor drug (top).… Read the rest